Cite
HARVARD Citation
Nassabein, R. et al. (2021). A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC). Cancer treatment and research communications. p. . [Online].